Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Papaporfyriou, S. Loukides, K. Kostikas, G. Hillas, D. Simoes, E. Konstantelou, S. Papiris, N. Koulouris, P. Bakakos, S. Loukides (Athens, Greece). Increased levels of osteopontin in sputum supernatant in patients with COPD. Eur Respir J 2012; 40: Suppl. 56, 305

Member's Comments

No comment yet.

Related content which might interest you: Increased levels of osteopontin in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005 Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients Source: Annual Congress 2009 - Novel approaches in asthma Year: 2009 Elevated levels of BALF galectin-9 in patients with interstitial pneumonia Source: Annual Congress 2009 - Airways remodelling Year: 2009 Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients Source: Eur Respir J 2015; 45: 1482-1485 Year: 2015 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Increased gelatinase and collagenase activity in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Assessment of growth factors production from sputum cell culture and sputum supernatant in COPD patients Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Expression of mRNA encoding IL-8 and CXCR‘s in blood and lavage of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 Induction-related changes in sputum neutrophils are associated with increased sputum levels of IL-8, but not sICAM Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007